Both in Surgical Instruments
Neuropace vs Carlsmed
Over the past year NPCE returned +32.6% and CARL returned +20.3%; their daily moves had a correlation of 0.28.
NPCE +32.6% CARL +20.3%Growth of $1, one year, split-adjusted
| Metric | NPCE | CARL |
|---|---|---|
| Price | $12.46 | $14.71 |
| Market cap | $427.7M | $401.5M |
| Today | +0.97% | −2.10% |
| 1 month | −5.7% | −3.9% |
| 6 months | −26.9% | +64.9% |
| Year to date | −19.3% | +19.1% |
| 1 year | +25.4% | +14.1% |
| Revenue growth (YoY) | +17.1% | — |
| Gross margin | 82.8% | 76.8% |
| Net margin | −27.2% | −55.5% |
| P/E (TTM) | — | — |
| Price / sales | 4.3× | 6.3× |
| Net cash | -$7.3M | $73.8M |
| Dividend yield | — | — |
| Volatility (60d) | 40.2% | 47.1% |
| Short % of float | 3.7% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).